{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:10:39Z","timestamp":1791864639973,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T00:00:00Z","timestamp":1421366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.msard.2015.01.005","type":"journal-article","created":{"date-parts":[[2015,1,24]],"date-time":"2015-01-24T01:51:47Z","timestamp":1422064307000},"page":"159-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":211,"title":["High doses of biotin in chronic progressive multiple sclerosis: A pilot study"],"prefix":"10.1016","volume":"4","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Sedel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Papeix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Bellanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Touitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lebrun-Frenay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Galanaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Gout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lyon-Caen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Tourbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2015.01.005_bib1","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neuroscience.2009.08.028","article-title":"Evidence for catabolic pathway of propionate metabolism in CNS: expression pattern of methylmalonyl-CoA mutase and propionyl-CoA carboxylase alpha-subunit in developing and adult rat brain","volume":"64","author":"Ballhausen","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.msard.2015.01.005_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0169-328X(03)00033-0","article-title":"Fatty acid synthesizing enzymes intrinsic to myelin","volume":"112","author":"Chakraborty","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.msard.2015.01.005_bib3","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2015.01.005_bib4","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJM200011163432001","article-title":"Relapses and progression of disability in multiple sclerosis","volume":"343","author":"Confavreux","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.msard.2015.01.005_bib5","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(09)60442-6","article-title":"Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial","volume":"373","author":"Goodman","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2015.01.005_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1385\/MN:22:1-3:021","article-title":"Carboxylation and anaplerosis in neurons and glia","volume":"22","author":"Hassel","year":"2000","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.msard.2015.01.005_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24009","article-title":"Multiple sclerosis: prospects and promise","volume":"74","author":"Hauser","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.msard.2015.01.005_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2015.01.005_bib11","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1586\/ern.12.59","article-title":"Neurodegeneration in multiple sclerosis: novel treatment strategies","volume":"12","author":"Luessi","year":"2012","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.msard.2015.01.005_bib12","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.msard.2015.01.005_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.msard.2015.01.005_bib14","series-title":"Basic neurochemistry: molecular, cellular and medical aspects","first-page":"51","article-title":"Myelin formation, structure and biochemistry","author":"Quarles","year":"2006"},{"key":"10.1016\/j.msard.2015.01.005_bib15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1523\/JNEUROSCI.3516-10.2011","article-title":"Regulation of oligodendrocyte development and myelination by glucose and lactate","volume":"31","author":"Rinholm","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.msard.2015.01.005_bib16","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1167\/iovs.02-1100","article-title":"How sensitive to clinical change are ETDRS logMAR visual acuity measurements?","volume":"44","author":"Rosser","year":"2003","journal-title":"Investig Ophthalmol Visual Sci"},{"key":"10.1016\/j.msard.2015.01.005_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/glia.1119","article-title":"Oligodendrocytes use lactate as a source of energy and as a precursor of lipids","volume":"36","author":"Sanchez-Abarca","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.msard.2015.01.005_bib18","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1212\/WNL.58.8.1294","article-title":"Quantitative functional measures in MS: what is a reliable change?","volume":"58","author":"Schwid","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2015.01.005_bib19","first-page":"S267","article-title":"A novel biotin sensitive leukodystrophy","volume":"34","author":"Sedel","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.msard.2015.01.005_bib20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1471-4159.1987.tb04107.x","article-title":"Biotin transport through the blood-brain barrier","volume":"48","author":"Spector","year":"1987","journal-title":"J Neurochem"},{"key":"10.1016\/j.msard.2015.01.005_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00971535","article-title":"Biotin transport and metabolism in the central nervous system","volume":"13","author":"Spector","year":"1988","journal-title":"Neurochem Res"},{"key":"10.1016\/j.msard.2015.01.005_bib22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrn3275","article-title":"Will the real multiple sclerosis please stand up?","volume":"13","author":"Stys","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.msard.2015.01.005_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.0b013e31827deb4c","article-title":"Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings","volume":"80","author":"Tabarki","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2015.01.005_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0165-3806(88)90158-7","article-title":"Acetyl-CoA carboxylase in rat brain. II. Immunocytochemical localization","volume":"471","author":"Tansey","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.msard.2015.01.005_bib25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00018-012-1096-0","article-title":"Structure and function of biotin-dependent carboxylases","volume":"70","author":"Tong","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.msard.2015.01.005_bib26","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/jn\/131.4.1271","article-title":"The clearance and metabolism of biotin administered intravenously to pigs in tracer and physiologic amounts is much more rapid than previously appreciated","volume":"131","author":"Wang","year":"2001","journal-title":"J Nutr"},{"key":"10.1016\/j.msard.2015.01.005_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molmed.2013.11.007","article-title":"Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis","volume":"20","author":"Witte","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.msard.2015.01.005_bib28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ajcn\/69.3.504","article-title":"Bioavailability of biotin given orally to humans in pharmacologic doses","volume":"69","author":"Zempleni","year":"1999","journal-title":"Am J Clin Nutr"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034815000061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034815000061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:36:59Z","timestamp":1761899819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034815000061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S2211034815000061"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2015.01.005","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High doses of biotin in chronic progressive multiple sclerosis: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2015.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}